Navigation Links
Sandia completes depleted uranium study

Sandia National Laboratories has completed a two-year study of the potential health effects associated with accidental exposure to depleted uranium (DU) during the 1991 Gulf War.

The study, "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study," performed by Sandia scientist Al Marshall, employs analytical capabilities used by Sandia's National Security Studies Department and examines health risks associated with uranium handling.

U.S. and British forces used DU in armor-piercing penetrator bullets to disable enemy tanks during the Gulf and Balkan wars. DU is a byproduct of the process used to enrich uranium for use in nuclear reactors and nuclear weapons. During the enrichment process, the fraction of one type of uranium (uranium-235) is increased relative to the fraction found in natural uranium. As a consequence, the uranium left over after the enrichment process (mostly uranium-238) is depleted in uranium-235 and is called depleted uranium.

The high density, low cost, and other properties of DU make it an attractive choice as an anti-tank weapon. However, on impact, DU particulate is dispersed in the surrounding air both within and outside the targeted vehicle and suspended particulate may be inhaled or ingested. Concerns have been raised that exposure to uranium particulate could have serious health problems including leukemia, cancers, and neurocognitive effects, as well as birth defects in the progeny of exposed veterans and civilians.

Marshall's study concluded that the reports of serious health risks from DU exposure are not supported by veteran medical statistics nor supported by his analysis. Only a few U.S. veterans in vehicles accidentally struck by DU munitions are predicted to have inhaled sufficient quantities of DU particulate to incur any significant health risk. For these individuals, DU-related risks include the possibility of temporary kidney damage and about a 1 percent chance of fatal c ancer.

Several earlier studies were carried out by the U.S. Department of Defense, by University Professors Fetter (University of Maryland) and von Hippel (Princeton), and by an Army sponsored team from Pacific Northwest National Laboratories and Los Alamos National Laboratory.

The conclusions from the Sandia study are consistent with these earlier studies. The Sandia study, however, also includes an analysis of potential health effects of DU fragments embedded as shrapnel in the bodies of some U.S. veterans. The Sandia study also looked at civilian exposures in greater detail, examined the potential risk of DU-induced birth defects in the children of exposed individuals, and provided a more detailed analysis of the dispersion of DU following impact with a number of targeted vehicles.

###

For a full copy of the report, download the following pdf file from http://www.sandia.gov/news-center/news-releases/2005/def-nonprolif-sec/snl-dusand.pdf : "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study"


'"/>

Source:DOE/Sandia National Laboratories


Related biology news :

1. Sandia work launched on space shuttle shows live cells influence growth of nanostructures
2. Sandia research to focus on early detection of harmful algal blooms
3. Sandia researchers discover way to see how a drug attaches to a cell
4. Sandia researchers take new approach to studying how cells respond to pathogens
5. Worlds largest rainforest drying experiment completes first phase
6. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
7. LIAI completes worlds most comprehensive analysis on influenza virus data
8. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
9. Canadian youth 4th highest in international obesity study
10. Frog peptides block HIV in lab study
11. Experimental shingles vaccine proves effective in nationwide study
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
Breaking Biology Technology: